| Primary |
| Atrial Fibrillation |
35.7% |
| Drug Use For Unknown Indication |
34.4% |
| Hypertension |
4.5% |
| Ventricular Arrhythmia |
4.1% |
| Product Used For Unknown Indication |
2.7% |
| Unevaluable Event |
2.7% |
| Heart Rate Abnormal |
2.3% |
| Arrhythmia |
1.8% |
| Heart Rate Increased |
1.8% |
| Congestive Cardiomyopathy |
1.4% |
| Ventricular Fibrillation |
1.4% |
| Ventricular Tachycardia |
1.4% |
| Atrial Flutter |
0.9% |
| High Density Lipoprotein Increased |
0.9% |
| Infection |
0.9% |
| Supraventricular Tachycardia |
0.9% |
| Syncope |
0.9% |
| Afib |
0.5% |
| Cardiovascular Event Prophylaxis |
0.5% |
| Pain Nos |
0.5% |
|
| Atrial Fibrillation |
19.7% |
| No Adverse Event |
10.6% |
| Adverse Event |
8.3% |
| Arrhythmia |
6.8% |
| Palpitations |
6.1% |
| Drug Ineffective |
5.3% |
| Vision Blurred |
5.3% |
| Dyspnoea |
3.8% |
| Heart Rate Decreased |
3.8% |
| Heart Rate Irregular |
3.8% |
| Myocardial Infarction |
3.8% |
| Ejection Fraction Decreased |
3.0% |
| Hyperhidrosis |
3.0% |
| Intraocular Pressure Decreased |
3.0% |
| Alopecia |
2.3% |
| Hair Texture Abnormal |
2.3% |
| Hiatus Hernia |
2.3% |
| Impaired Gastric Emptying |
2.3% |
| Thrombosis |
2.3% |
| Thyroid Function Test Abnormal |
2.3% |
|
| Secondary |
| Atrial Fibrillation |
26.3% |
| Hypertension |
15.8% |
| Drug Use For Unknown Indication |
9.6% |
| Bronchitis |
5.3% |
| Cerebrovascular Accident Prophylaxis |
5.3% |
| Influenza |
5.3% |
| Cardiovascular Disorder |
4.4% |
| Heart Rate Abnormal |
3.5% |
| Supraventricular Tachycardia |
3.5% |
| Congestive Cardiomyopathy |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Ventricular Tachycardia |
2.6% |
| Anxiety |
1.8% |
| Arteriosclerosis |
1.8% |
| Blood Cholesterol |
1.8% |
| Cardiac Disorder |
1.8% |
| High Density Lipoprotein Decreased |
1.8% |
| Unevaluable Event |
1.8% |
| Ventricular Arrhythmia |
1.8% |
| Arrhythmia |
0.9% |
|
| Vision Blurred |
13.3% |
| Palpitations |
11.1% |
| Chest Pain |
6.7% |
| Heart Rate Irregular |
6.7% |
| Bradycardia |
4.4% |
| Cardiac Pacemaker Insertion |
4.4% |
| Diarrhoea |
4.4% |
| Drug Ineffective |
4.4% |
| Drug Interaction |
4.4% |
| Electrocardiogram Qt Prolonged |
4.4% |
| Headache |
4.4% |
| Heart Rate Decreased |
4.4% |
| Pain |
4.4% |
| Thrombosis |
4.4% |
| Transient Ischaemic Attack |
4.4% |
| Walking Aid User |
4.4% |
| Alopecia |
2.2% |
| Atrial Fibrillation |
2.2% |
| Blood Sodium Decreased |
2.2% |
| Cardiac Arrest |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.1% |
| Atrial Fibrillation |
12.8% |
| Drug Use For Unknown Indication |
12.3% |
| Multiple Myeloma |
7.6% |
| Depression |
5.1% |
| Arthritis |
4.5% |
| Hypertension |
4.5% |
| Arrhythmia |
3.9% |
| Angina Pectoris |
3.6% |
| Pain |
3.3% |
| Blood Cholesterol Increased |
2.3% |
| Diabetes Mellitus |
2.3% |
| Cardiac Disorder |
2.2% |
| Cardiac Failure Congestive |
1.4% |
| Prophylaxis |
1.4% |
| Pulmonary Arterial Hypertension |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Coronary Artery Bypass |
1.3% |
| Insomnia |
1.3% |
|
| Weight Decreased |
12.4% |
| Vomiting |
10.3% |
| Wheezing |
9.2% |
| Tooth Extraction |
6.5% |
| Vision Blurred |
5.4% |
| Urinary Tract Infection |
4.9% |
| Death |
4.3% |
| Diarrhoea |
4.3% |
| Nausea |
4.3% |
| Cerebrovascular Accident |
3.8% |
| Malaise |
3.8% |
| Renal Failure Acute |
3.8% |
| Upper Respiratory Tract Infection |
3.8% |
| Weight Increased |
3.8% |
| Atrial Fibrillation |
3.2% |
| Oedema Peripheral |
3.2% |
| Pain |
3.2% |
| Stress |
3.2% |
| Venous Insufficiency |
3.2% |
| Ventricular Tachycardia |
3.2% |
|
| Interacting |
| Hypertonic Bladder |
33.3% |
| Drug Use For Unknown Indication |
16.7% |
| Hypertension |
16.7% |
| Pneumonia |
16.7% |
| Atrial Fibrillation |
8.3% |
| Infection |
8.3% |
|
| Torsade De Pointes |
33.3% |
| Drug Interaction |
22.2% |
| Urine Odour Abnormal |
22.2% |
| Cardiac Flutter |
11.1% |
| Vomiting |
11.1% |
|
